Controversies in preconditioning

Cardiovascular Drugs and Therapy

Volumn 10, Issue 6, 1997, Pages 767-773

  De Jong, Jan Willem ^a   De Jonge, Robert ^a   Marchesani, Andrea ^b   Janssen, Maarten ^a   Bradamante, Silvia ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

5' nucleotidase; Adenosine; Angioplasty; ATPase; Catecholamines; Glycolysis; Preconditioning; Protein kinase C

Indexed keywords

ADENOSINE; BRADYKININ; HYDROLASE; NORADRENALIN; PROTEIN KINASE C; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ACIDOSIS; CLINICAL PROTOCOL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DILATATION; ENZYME ACTIVATION; ENZYME REGULATION; GLYCOLYSIS; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE;

EID: 0030980490     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00053035     Document Type: Review

References (62)

1. Alkhulaifi AM, Yellon DM, Pugsley WB. Preconditioning the human heart during aorto-coronary bypass surgery. Eur J Cardiothorac Surg 1994;8:270-276.
2. Andreotti F, Pasceri V, Hackett DR, Davies GJ, Haider AW, Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 1996;334:7-12.
3. Anzai T, Yoshikawa T, Asakura Y, et al. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction. J Am Coll Cardiol 1995;26:319-327.
4. Asimakis GK. Myocardial glycogen depletion cannot explain the cardioprotective effects of ischemic preconditioning in the rat heart. J Mol Cell Cardiol 1996;28:563-570.
5. Barbosa V, Sievers RE, Zaugg CE, Wolfe CL. Preconditioning ischemia time determines the degree of glycogen depletion and infarct size reduction in rat hearts. Am Heart J 1996;131:224-330.
6. Bradamante S, Piccinini F, Delu C, Janssen M, De Jong JW. NMR evaluation of changes in myocardial high energy metabolism produced by repeated short periods of ischemia. Biochim Biophys Acta 1995;1243:1-8.
7. Claeys MJ, Vrints CJ, Bosmans JM, Conraads VM, Snoeck JP. Aminophylline inhibits adaptation to ischaemia during angioplasty. Role of adenosine in ischaemic preconditioning. Eur Heart J 1996;17:539-544.
8. Cohen MV, Walsh RS, Goto M, Downey JM. Hypoxia preconditions rabbit myocardium via adenosine and catecholamine release. J Mol Cell Cardiol 1995;27:1527-1534.
9. Cribier A, Korsatz L, Koning R, et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: A prospective study. J Am Coll Cardiol 1992;20:578-586.
10. Cupples LA, Gagnon DR, Wong ND, Ostfeld AM, Kannel WB. Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: The Framingham Study. Am Heart J 1993;125:863-872.
11. De Jong JW, Cargnoni A, Huizer T, Ferrari R, Bonnier JJRM. Lactate and hypoxanthine release after coronary angioplasty: No evidence of preconditioning (abstr). J Mol Cell Cardiol 1993;25(Suppl 1):S37.
12. De Jong JW, Cargnoni A, Bradamante S, et al. Intermittent v continuous ischemia decelerates adenylate breakdown and prevents norepinephrine release in reperfused rabbit heart. J Mol Cell Cardiol 1995;27:659-671.
13. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Hermann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 1990;82: 2044-2051.
14. Finegan BA, Lopaschuk GD, Coulson CS, Clanachan AS. Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation 1993;87:900-908.
15. Fralix TA, Murphy E, London RE, Steenbergen C. Protective effects of adenosine in the perfused rat heart: Changes in metabolism and intracellular ion homeostasis. Am J Physiol 1993;264:C986-994.
16. Gho BCG, Eskildsen-Helmond YEG, De Zeeuw S, Lamers JMJ, Verdouw PD. Does protein kinase C play a pivotal role in the mechanisms of ischemic preconditioning? Cardiovasc Drugs Ther 1996;10:775-786.
17. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995;77:611-621.
18. Goto M, Tsuchida A, Liu Y, Cohen MV, Downey JM. Transient inhibition of glucose uptake mimics ischemic preconditioning by salvaging ischemic myocardium in the rabbit heart. J Mol Cell Cardiol 1995;27:1883-1894.
19. Headrick JP. Ischemic preconditioning: Bioenergetic and metabolic changes and the role of endogenous adenosine. J Mol Cell Cardiol 1996;28:1227-1240.
20. 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation 1995;92:2259-2265.
21. Ikonomidis JS, Tumiati LC, Weisel RD, Mickle DAG, Li R-K. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovasc Res 1994;28:1285-1291.
22. Janier MF, Vanoverschelde J-LJ, Bergmann SR. Adenosine protects ischemic and reperfused myocardium by receptor-mediated mechanisms. Am J Physiol 1993;264: H163-170.
23. Janier MF, Vanoverschelde J-LJ, Bergmann SR. Ischemic preconditioning stimulates anaerobic glycolysis in the isolated rabbit heart. Am J Physiol 1994;267:H1353-1360.
24. Jenkins DP, Steare SE, Yellon DM. Preconditioning the human myocardium: Recent advances and aspirations for the development of a new means of cardioprotection in clinical practice. Cardiovasc Drugs Ther 1995;9:739-747.
25. Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Circulation 1993;87:208-215.
26. 1-Adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation 1995;91:2226-2234.
27. Kobara M, Tatsumi T, Matoba S, et al. Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts. J Mol Cell Cardiol 1996;28:417-428.
28. Lee HT, LaFaro RJ, Reed GE. Pretreatment of human myocardium with adenosine during open heart surgery. J Card Surg 1995;10:665-676.
29. Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994;26: 661-668.
30. Lochner A, Pentz A, Williams K, Tromp E, Harper IS. Substrate effects on sarcolemmal permeability in the normoxie and hypoxic perfused rat heart. Basic Res Cardiol 1996;91:64-78.
31. 1-adrenergic signal transduction pathway or protein kinase C in the isolated rat heart. Cardiovasc Drugs Ther 1996;10: 125-136.
32. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990;66:913-931.
33. Neely JR, Grotyohann LW. Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res 1984;55:816-824.
34. Opie LH. The mechanism of myocyte death in ischaemia. Eur Heart J 1993;14(Suppl G):31-33.
35. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 1995;91:291-297.
36. Przyklenk K, Kloner RA. Preconditioning: A balanced perspective. Br Heart J 1995;74:575-577.
37. Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation 1995;92: 1546-1557.
38. Przyklenk K, Zhao L, Kloner RA, Elliott GT. Reduction of infarct size with ischemic preconditioning and monophosphoryl lipid A: Role of adenosine regulating enzymes? Am J Physiol 1996, in press.
39. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB. Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 1986;251: H1306-1315.
40. Rouslin W. Regulation of the mitochondrial ATPase in situ in cardiac muscle: Role of the inhibitor subunit. J Bioenerg Biomembr 1991;23:873-888.
41. Schaefer S, Carr LJ, Prussel E, Ramasamy R. Effects of glycogen depletion on ischemic injury in isolated rat hearts: Insights into preconditioning. Am J Physiol 1995;268: H935-944.
42. Schaefer S, Prussel E, Carr LJ. Requirement of glycolytic substrate for metabolic recovery during moderate low flow ischemia. J Mol Cell Cardiol 1995;27:2167-2176.
43. Schneider CA, Taegtmeyer H. Fasting in vivo delays myocardial cell damage after brief periods of ischemia in the isolated working rat heart. Circ Res 1991;68:1045-1050.
44. Schömig A, Dart AM, Dietz R, Mayer E, Kübler W. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally medicated release. Circ Res 1984;55:689-701.
45. Seyfarth M, Richardt G, Mizsnyak A, Kurz T, Schömig A. Transient ischemia reduces norepinephrine release during sustained ischemia. Neural preconditioning in isolated rat heart. Circ Res 1996;78:573-580.
46. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Cire Res 1995;77:1030-1035.
47. + channel blocker. Circulation 1994;90:700-705.
48. 1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. Eur Heart J 1996; 17:846-853.
49. Toombs CF, Wiltse AL, Shebuski RJ. Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium. Implication of norepinephrine release in the preconditioning effect. Circulation 1993;88:2351-2358.
50. Vander Heide RS, Schwartz LM, Jennings RB, Reimer KA. Effect of catecholamine depletion on myocardial infarct size in dogs: Role of catecholamines in ischemic preconditioning. Cardiovasc Res 1995;30:656-662.
51. Vander Heide RS, Delyani JA, Jennings RB, Reimer KA, Steenbergen C. Reducing lactate accumulation does not attenuate lethal ischemic injury in isolated perfused rat hearts. Am J Physiol 1996;270:H38-44.
52. Vander Heide RS, Hill ML, Reimer KA, Jennings RB. Effect of reversible ischemia on the activity of the mitochondrial ATPase: Relationship to ischemic preconditioning. J Mol Cell Cardiol 1996;28:103-112.
53. Van der Vusse GJ, Van der Veen FH, Flameng W, et al. A biochemical and ultrastructural study on myocardial changes during aorto-coronary bypass surgery: St. Thomas Hospital cardioplegia versus intermittent aortic cross-clamping at 34 and 25°C. Eur Surg Res 1986;18:1-11.
54. Vanoverschelde J-LJ, Janier MF, Bakke JE, Marshall DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol 1994;267:H1785-1794.
55. ATP channel. Am J Physiol 1994;266:H829-839.
56. 0-ATPase. Circulation 1995;91:2810-2818.
57. Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DM. Preconditioning in isolated superperfused human muscle. J Mol Cell Cardiol 1995;27:1349-1357.
58. Weselchouch EO, Baird AJ, Sleph PG, Dzwonczyk S, Murray HN, Grover GJ. Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heart. Cardiovasc Res 1995;29:126-132.
59. Wolfe CL, Sievers RE, Visseren FLJ, Donnelly TJ. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 1993;87:881-892.
60. 1-adenosine receptors. Am J Physiol 1989;257:H1952-1957.
61. ATP channels. Circulation 1994;89:1229-1236.
62. Yellon DM, Baxter GF. A "second window of protection" or delayed preconditioning phenomenon: Future horizons for myocardial protection? J Mol Cell Cardiol 1995;27: 1023-1034.